| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662281217P | 2016-01-21 | 2016-01-21 |
| Publication Number | Publication Date |
|---|---|
| SG10202000645SAtrue SG10202000645SA (en) | 2020-03-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202000645SASG10202000645SA (en) | 2016-01-21 | 2017-01-20 | Neutralization of Inhibitory Pathways in Lymphocytes |
| SG11201805831RASG11201805831RA (en) | 2016-01-21 | 2017-01-20 | Neutralization of inhibitory pathways in lymphocytes |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805831RASG11201805831RA (en) | 2016-01-21 | 2017-01-20 | Neutralization of inhibitory pathways in lymphocytes |
| Country | Link |
|---|---|
| US (3) | US10870700B2 (en) |
| EP (2) | EP3868787A1 (en) |
| JP (3) | JP7301538B2 (en) |
| KR (1) | KR20180101549A (en) |
| CN (2) | CN116327916A (en) |
| AU (2) | AU2017208554B2 (en) |
| CA (1) | CA3012055A1 (en) |
| CY (1) | CY1124212T1 (en) |
| DK (1) | DK3405495T3 (en) |
| ES (1) | ES2871112T3 (en) |
| HR (1) | HRP20210778T1 (en) |
| HU (1) | HUE054356T2 (en) |
| IL (1) | IL260464B (en) |
| LT (1) | LT3405495T (en) |
| PL (1) | PL3405495T3 (en) |
| PT (1) | PT3405495T (en) |
| RS (1) | RS61901B1 (en) |
| RU (1) | RU2769569C2 (en) |
| SG (2) | SG10202000645SA (en) |
| SI (1) | SI3405495T1 (en) |
| SM (1) | SMT202100280T1 (en) |
| WO (1) | WO2017125532A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9795674B2 (en) | 2010-02-26 | 2017-10-24 | Novo Nordisk A/S | Stable antibody containing compositions |
| WO2012172102A1 (en) | 2011-06-17 | 2012-12-20 | Novo Nordisk A/S | Selective elimination of erosive cells |
| WO2015109391A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
| CN107001466B (en) | 2014-09-16 | 2021-10-26 | 依奈特制药公司 | Neutralization of inhibitory pathways in lymphocytes |
| SG11201701387SA (en) | 2014-09-16 | 2017-03-30 | Innate Pharma | Treatment regimens using anti-nkg2a antibodies |
| EP3209687A1 (en) | 2014-10-23 | 2017-08-30 | Innate Pharma | Treatment of cancers using anti-nkg2a agents |
| KR102554507B1 (en) | 2015-07-24 | 2023-07-11 | 이나뜨 파르마 에스.에이. | Method for detecting tissue-infiltrating NK cells |
| SI3405495T1 (en)* | 2016-01-21 | 2021-08-31 | Innate Pharma | Neutralization of inhibitory pathways in lymphocytes |
| JP7455749B2 (en) | 2018-03-13 | 2024-03-26 | インネート ファーマ | Treatment of head and neck cancer |
| US20210024633A1 (en) | 2018-03-28 | 2021-01-28 | Ensemble Group Holdings | Methods of treating cancer in subjects having dysregulated lymphatic systems |
| EA202092696A1 (en)* | 2018-05-15 | 2021-04-05 | Медиммун Лимитед | CANCER TREATMENT |
| MY205758A (en)* | 2018-11-16 | 2024-11-12 | Bristol Myers Squibb Co | Anti-nkg2a antibodies and uses thereof |
| JP7284256B2 (en) | 2019-08-12 | 2023-05-30 | ビオンド バイオロジクス リミテッド | Antibodies against ILT2 and uses thereof |
| CN114901689A (en)* | 2019-10-14 | 2022-08-12 | 先天制药公司 | Treatment of cancer with ILT-2 inhibitors |
| MX2023001776A (en)* | 2020-08-12 | 2023-03-10 | Biond Biologics Ltd | Antibodies against ilt2 and use thereof. |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| GB9725764D0 (en) | 1997-12-04 | 1998-02-04 | Isis Innovation | HLA-E binding |
| JP4524181B2 (en) | 2002-05-30 | 2010-08-11 | マクロジェニクス，インコーポレーテッド | CD16A binding protein and use for treatment of immune disorders |
| CA2532547C (en)* | 2003-07-24 | 2020-02-25 | Innate Pharma | Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| NO346624B1 (en) | 2004-12-28 | 2022-11-07 | Univ Di Genova | Monoclonal antibody against NKG2A |
| CA3151350A1 (en) | 2005-05-09 | 2006-11-16 | E. R. Squibb & Sons, L.L.C. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| CA3201163A1 (en) | 2005-07-01 | 2007-01-11 | E. R. Squibb & Sons, L.L.C. | Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| US8206709B2 (en) | 2006-06-30 | 2012-06-26 | Novo Nordisk A/S | Anti-NKG2A antibodies and uses thereof |
| CN102131828B (en) | 2007-06-18 | 2015-06-17 | 默沙东有限责任公司 | Antibody against human programmed death receptor PD-1 |
| US20090028857A1 (en) | 2007-07-23 | 2009-01-29 | Cell Genesys, Inc. | Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| WO2009092805A1 (en) | 2008-01-24 | 2009-07-30 | Novo Nordisk A/S | Humanized anti-human nkg2a monoclonal antibody |
| CN101970499B (en) | 2008-02-11 | 2014-12-31 | 治疗科技公司 | Monoclonal Antibodies for Cancer Therapy |
| US8168757B2 (en) | 2008-03-12 | 2012-05-01 | Merck Sharp & Dohme Corp. | PD-1 binding proteins |
| PT4209510T (en) | 2008-12-09 | 2024-04-02 | Hoffmann La Roche | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| ES2646863T3 (en) | 2009-11-24 | 2017-12-18 | Medimmune Limited | B7-H1 specific binding agents |
| US9795674B2 (en) | 2010-02-26 | 2017-10-24 | Novo Nordisk A/S | Stable antibody containing compositions |
| KR101970025B1 (en) | 2011-04-20 | 2019-04-17 | 메디뮨 엘엘씨 | Antibodies and other molecules that bind b7-h1 and pd-1 |
| WO2012172102A1 (en) | 2011-06-17 | 2012-12-20 | Novo Nordisk A/S | Selective elimination of erosive cells |
| TWI835048B (en) | 2011-08-01 | 2024-03-11 | 美商建南德克公司 | Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
| EP2812011B1 (en)* | 2012-02-08 | 2020-01-15 | Glycostem Therapeutics B.V. | Ex vivo nk cell differentiation from cd34+ hematopoietic cells |
| DK2904011T3 (en)* | 2012-10-02 | 2017-12-04 | Bristol Myers Squibb Co | COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR TREATMENT OF CANCER |
| MX370449B (en) | 2013-12-12 | 2019-12-13 | Shanghai hengrui pharmaceutical co ltd | Pd-1 antibody, antigen-binding fragment thereof, and medical application thereof. |
| AU2015307316A1 (en) | 2014-08-28 | 2017-03-09 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | CD94/NKG2A and/or CD94/NKG2B antibody, vaccine combinations |
| SG11201701387SA (en) | 2014-09-16 | 2017-03-30 | Innate Pharma | Treatment regimens using anti-nkg2a antibodies |
| CN107001466B (en)* | 2014-09-16 | 2021-10-26 | 依奈特制药公司 | Neutralization of inhibitory pathways in lymphocytes |
| EP3209687A1 (en) | 2014-10-23 | 2017-08-30 | Innate Pharma | Treatment of cancers using anti-nkg2a agents |
| SI3405495T1 (en)* | 2016-01-21 | 2021-08-31 | Innate Pharma | Neutralization of inhibitory pathways in lymphocytes |
| Publication | Publication Date | Title |
|---|---|---|
| ZA201702642B (en) | Neutralization of inhibitory pathways in lymphocytes | |
| IL260464B (en) | Neutralization of inhibitory pathways in lymphocytes | |
| IL288147A (en) | Ras inhibitory peptides and uses thereof | |
| ZA201800542B (en) | Threaded fastener | |
| EP3316884A4 (en) | Therapeutic inhibitory compouds | |
| EP3344400A4 (en) | BIO-PRINTER OF MICROTISSU IN THREE DIMENSIONS | |
| ZA201707923B (en) | Medical bathing device | |
| PL3285606T3 (en) | Body protection | |
| ZA201800413B (en) | Dry suit | |
| IL260193A (en) | tlr inhibitory oligonucleotides and their use | |
| HUE055790T2 (en) | Multi-patch threaded fastener | |
| SG11201701717UA (en) | Antiviral agents and uses thereof | |
| HK40091504A (en) | Neutralization of inhibitory pathways in lymphocytes | |
| HK40110316A (en) | Neutralization of inhibitory pathways in lymphocytes | |
| SG11201710519PA (en) | Evaluation of inhibitory circuit and use thereof | |
| IL247732A0 (en) | Heparanase inhibitory peptides and use thereof for treating clinical pathologies | |
| AU5563P (en) | Viclow Acmena smithii | |
| GB201607978D0 (en) | Inhibitory compounds | |
| GB201521152D0 (en) | Dictionary/thesaurus | |
| GB201517185D0 (en) | Towel | |
| GB201508876D0 (en) | Sanitary protection | |
| GB201509863D0 (en) | Shower arrangement | |
| GB201508203D0 (en) | Water Ect |